[S-28] Symposium 28「Hyperkinetic movement disorders: update」

[S-28-3] Is dystonia a basal ganglion dysfunction or a network disorder? perspectives from neurophysiology

Rou-Shayn Chen (Chang Gung Memorial Hospital)

Qualifications:
•Dr. Rou-Shayn Chen chaired the Division of Movement Disorders, Department of
Neurology, Chang Gung Memorial Hospital for more than 10 years since 2004 to
2014. He was one of the pioneers to use botulinum toxin in Taiwan. During the past
decade, He also built up one registration system for clinical follow-up in detail of
Parkinson’s disease in Taiwan.

Designation(s) & Affiliation(s):
•Attending physician and Associate Professor Chang Gung Memorial Hospital, Taipei, Taiwan
•Director, Treatment Center of Parkinson’s Disease and Related Movement Disorders, Chang Gung Memorial Hospital

Areas of Specialization:
•Movement disorders with a special focus on Parkinson’s disease, dystonia and cerebellar degeneration
•Neurophysiology with a focus on neuromodulation by non-invasive brain stimulation
•Botulinum Toxin injection
•Clinical Neuropharmacology with a focus on levodopa and glutamate

Achievements & Awards:
•President, Taiwan Movement Disorders Society (2011-2013)
•Executive Committee Member, MDS-Asian Oceanian Section (2013-2017)
•President, Taiwan Neurological Society (2019-2021)
•Chair and President, Asian Oceanian Congress of Neurology, Taipei, Taiwan, (2021)
•WFN National Delegate of Taiwan Neurological Society ( 2021~)

Research Interests:
•Movement disorders focus on Parkinson’s disease, dystonia, and cerebellar degeneration
•Neurophysiology focus on neuromodulation by non-invasive brain stimulation
•Botulinum Toxin injection
•Clinical Neuropharmacology focus on levodopa and glutamate